Analysis of Changes in Medication Prescriptions After Hospitalization for 4 Disciplines: Gerontology, Diabetology, Cardiology and Rheumatology: Medical, Pharmaceutical and Economic Aspects
- Conditions
- DiabetesCardiac DiseaseRheumatic Diseases
- Interventions
- Other: collection of prescription data
- Registration Number
- NCT03371303
- Lead Sponsor
- Assistance Publique Hopitaux De Marseille
- Brief Summary
The modifications of the medicinal treatments secondary to the hospitalizations have multiple reasons: reassessment of the previous treatment (conciliation), new therapeutic necessities, potential risk of iatrogeny or of drug interaction, restrictions of the therapeutic booklet, classification in reserve or hospital prescription ... These modifications are potentially generating extra costs for the Health Insurance and are monitored under the terms of the Contract of Good Use. The aims of this analysis are to define the medical-pharmaceutical rationale of the treatment changes imposed by hospitalization in a university-hospital center, their influence on the security of the medical treatment of patients and their financial implications for healthcare organizations
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 400
Not provided
Not provided
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description cardiology collection of prescription data - rheumatology collection of prescription data - geriatrics collection of prescription data - diabetology collection of prescription data -
- Primary Outcome Measures
Name Time Method entry orders before hospitalization 15 months exit orders after hospitalization 15 months
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Assistance Publique Hôpitaux de Marseille
🇫🇷Marseille, France